Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.43% |
| 2 | Energy | 4.72% |
| 3 | Technology | 4.42% |
| 4 | Financials | 3.4% |
| 5 | Consumer Discretionary | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNDK
201
CALL
DELISTED
SANDISK CORP
SNDK
| $81.6M | 0.08% |
841,400
+152,300
| +22% | +$14.9M |
|
202
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.6B
| $81.6M | 0.08% |
4,042,032
+679,501
| +20% | +$13.7M |
|
203
Eli Lilly
LLY
$1.04T
| $81.3M | 0.08% |
1,269,534
-66,566
| -5% | -$4.21M |
|
|
MBLY
204
PUT
DELISTED
Mobileye N.V.
MBLY
| $81.1M | 0.08% |
+1,530,500
| New | +$66.8M |
|
|
YHOO
205
DELISTED
Yahoo Inc
YHOO
| $80.2M | 0.08% |
2,006,242
-113,895
| -5% | -$4.27M |
|
206
AstraZeneca
AZN
$250B
| $79.8M | 0.08% |
1,124,394
+236,693
| +27% | +$17.3M |
|
207
PUT
Verizon
VZ
$193B
| $79.8M | 0.08% |
1,629,120
+618,172
| +61% | +$30.7M |
|
208
3M
MMM
$93.9B
| $78.9M | 0.08% |
669,182
-16,119
| -2% | -$1.94M |
|
|
SNDK
209
DELISTED
SANDISK CORP
SNDK
| $78.4M | 0.08% |
808,521
+227,260
| +39% | +$22.2M |
|
|
AET
210
CALL
DELISTED
Aetna Inc
AET
| $78.1M | 0.08% |
964,200
+861,000
| +834% | +$70.1M |
|
211
Goldman Sachs
GS
$313B
| $77.9M | 0.07% |
425,748
-67,834
| -14% | -$11.9M |
|
212
iShares Core S&P 500 ETF
IVV
$898B
| $77.4M | 0.07% |
391,109
-42,987
| -10% | -$8.55M |
|
213
Teva Pharmaceuticals
TEVA
$40.5B
| $77.4M | 0.07% |
1,460,764
+208,823
| +17% | +$11.1M |
|
214
Duke Energy
DUK
$96.2B
| $77M | 0.07% |
1,040,968
+114,552
| +12% | +$8.36M |
|
|
MRO
215
DELISTED
Marathon Oil Corporation
MRO
| $75.7M | 0.07% |
2,046,469
+24,470
| +1% | +$970K |
|
216
American Express
AXP
$236B
| $75.7M | 0.07% |
870,158
+268,123
| +45% | +$24.1M |
|
|
WBA
217
DELISTED
Walgreens Boots Alliance
WBA
| $75.7M | 0.07% |
1,282,249
+22,317
| +2% | +$1.46M |
|
218
PUT
Micron Technology
MU
$1.01T
| $75.5M | 0.07% |
2,221,800
-878,700
| -28% | -$28.5M |
|
219
CALL
United Rentals
URI
$72.3B
| $74.9M | 0.07% |
674,400
+186,700
| +38% | +$21M |
|
220
PUT
Chevron
CVX
$371B
| $74.8M | 0.07% |
628,900
+257,900
| +70% | +$32.9M |
|
221
ICL Group
ICL
$6.75B
| $74.8M | 0.07% |
+10,685,387
| New | +$76.5M |
|
222
CALL
IBM
IBM
$222B
| $74.7M | 0.07% |
413,484
-79,496
| -16% | -$14.5M |
|
223
Williams Companies
WMB
$87.8B
| $74.6M | 0.07% |
1,355,697
-163,624
| -11% | -$9.4M |
|
224
CALL
AbbVie
ABBV
$435B
| $73.8M | 0.07% |
1,294,900
+1,159,000
| +853% | +$64.3M |
|
225
Caterpillar
CAT
$401B
| $73.6M | 0.07% |
742,958
+92,638
| +14% | +$9.82M |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.